Europe Set to Drive Monoclonal Antibodies Market
As per our new research report “Global Monoclonal Antibody Market Analysis”, Europe is the second largest market for mAbs in the world. Our study indicates that ten major mAb products are commercially available in Europe, including Remicade, Zevalin, Campath, Herceptin, Rituxan, Simulect, Zenapax, Synagis, ReoPro, and the fully human Mab Humira. In fact, physicians are increasingly adopting mAbs because of its superior side effect profile in the European region.
View full press release